Cardiome Pharma Stock Price, News & Analysis (TSE:COM)

C$1.92 0.00 (0.00 %)
(As of 01/19/2018 04:00 PM ET)
Previous CloseC$1.92
Today's RangeC$1.90 - C$1.95
52-Week RangeC$1.64 - C$6.06
Volume2,100 shs
Average Volume20,363 shs
Market CapitalizationC$66.39 million
P/E Ratio-1.85
Dividend YieldN/A
Beta0.5

About Cardiome Pharma (TSE:COM)

Cardiome Pharma Corp. (Cardiome) is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of cardiovascular therapies for heart disease. The Company's segments are Europe and Rest of World. Cardiome has two marketed, in-hospital, cardiology products, which include BRINAVESS (vernakalant IV), approved in Europe and other territories for the conversion of onset atrial fibrillation (AF) to sinus rhythm in adults, and AGGRASTAT (tirofiban hydrochloride (HCl)), indicated for use in patients with acute coronary syndrome. Cardiome also commercializes ESMOCARD and ESMOCARD LYO (esmolol hydrochloride), a short-acting beta-blocker used to control heart rate in various cardiovascular indications, in select European markets. Cardiome has also licensed TREVYENT, a development-stage drug device combination product that is under development for pulmonary arterial hypertension, in certain regions outside the United States.

Receive COM News and Ratings via Email

Sign-up to receive the latest news and ratings for COM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorHealthcare
SymbolTSE:COM
CUSIPN/A
Phone+1-604-6776905

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-1.84615384615385
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSC($1.04)
Net IncomeN/A
Net Margins-110.00%
Return on Equity-101.85%
Return on Assets-37.39%

Miscellaneous

EmployeesN/A
Outstanding Shares34,629,000

Cardiome Pharma (TSE:COM) Frequently Asked Questions

What is Cardiome Pharma's stock symbol?

Cardiome Pharma trades on the Toronto Stock Exchange (TSX) under the ticker symbol "COM."

How were Cardiome Pharma's earnings last quarter?

Cardiome Pharma Corp (TSE:COM) posted its quarterly earnings results on Tuesday, November, 14th. The biopharmaceutical company reported ($0.25) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.20) by $0.05. Cardiome Pharma had a negative net margin of 110.00% and a negative return on equity of 101.85%. View Cardiome Pharma's Earnings History.

When will Cardiome Pharma make its next earnings announcement?

Cardiome Pharma is scheduled to release their next quarterly earnings announcement on Tuesday, March, 6th 2018. View Earnings Estimates for Cardiome Pharma.

Who are some of Cardiome Pharma's key competitors?

Who are Cardiome Pharma's key executives?

Cardiome Pharma's management team includes the folowing people:

  • W. James O'Shea, Independent Chairman of the Board
  • William L. Hunter M.D., President, Chief Executive Officer, Director (Age 52)
  • Justin A. Renz C.P.A., M.S.T., M.B., Chief Financial Officer (Age 45)
  • Sheila M. Grant, Chief Operating Officer
  • David D. McMasters J.D., Corporate General Counsel
  • David C. Dean, Chief Business Development Officer
  • Jennifer Archibald CPA, Chief Business Operations Officer
  • Hugues Sachot, Chief Commercial Officer
  • Richard M. Glickman LL.D., Lead Independent Director (Age 57)
  • Mark H.N. Corrigan M.D., Independent Director (Age 60)

How do I buy Cardiome Pharma stock?

Shares of Cardiome Pharma and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Cardiome Pharma's stock price today?

One share of Cardiome Pharma stock can currently be purchased for approximately C$1.92.

How big of a company is Cardiome Pharma?

Cardiome Pharma has a market capitalization of C$66.39 million.

How can I contact Cardiome Pharma?

Cardiome Pharma's mailing address is 1441 Creekside Dr 6th Floor, VANCOUVER, BC V6J 4S7, Canada. The biopharmaceutical company can be reached via phone at +1-604-6776905.


MarketBeat Community Rating for Cardiome Pharma (COM)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  59 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  110
MarketBeat's community ratings are surveys of what our community members think about Cardiome Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cardiome Pharma (TSE:COM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Cardiome Pharma (TSE:COM) Consensus Price Target History

Price Target History for Cardiome Pharma (TSE:COM)

Cardiome Pharma (TSE:COM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/17/2017HC WainwrightReiterated RatingBuyView Rating Details
11/9/2016Bloom BurtonReiterated RatingBuyView Rating Details
(Data available from 1/20/2016 forward)

Earnings

Cardiome Pharma (TSE:COM) Earnings History and Estimates Chart

Earnings by Quarter for Cardiome Pharma (TSE:COM)

Cardiome Pharma (TSE COM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2018        
11/14/2017Q3 2017C($0.20)C($0.25)ViewN/AView Earnings Details
8/8/2017Q2 2017C($0.24)C($0.35)ViewN/AView Earnings Details
5/15/2017Q1 2017C($0.20)C($0.26)ViewN/AView Earnings Details
3/7/2017Q4 2016C($0.24)C($0.24)ViewN/AView Earnings Details
11/7/2016Q3 2016C($0.40)C($0.24)ViewN/AView Earnings Details
8/9/2016Q2 2016C($0.31)C($0.48)ViewN/AView Earnings Details
5/13/2016Q1 2016C($0.19)C($0.08)ViewN/AView Earnings Details
3/10/2016Q4 2015C($0.22)C($0.49)ViewN/AView Earnings Details
11/13/2015Q3 2015C($0.32)C($0.40)ViewN/AView Earnings Details
8/5/2015Q2 2015C($0.53)ViewN/AView Earnings Details
5/13/2015Q1 2015C($0.28)ViewN/AView Earnings Details
3/12/2015Q4 2014C($0.50)ViewN/AView Earnings Details
11/7/2014Q3 2014C($0.16)C($0.30)ViewN/AView Earnings Details
8/11/2014C($0.18)C($0.28)C$7.37 millionC$8.40 millionViewN/AView Earnings Details
5/12/2014Q1 2014C($0.24)C($0.22)ViewN/AView Earnings Details
3/28/2014C($0.34)C($0.45)ViewN/AView Earnings Details
11/6/2013Q3 2013C($0.30)ViewN/AView Earnings Details
8/2/2013Q2 2013C($0.23)ViewN/AView Earnings Details
5/13/2013Q1 2013C$0.39ViewN/AView Earnings Details
3/15/2013Q4 2012C($0.20)C($0.30)ViewN/AView Earnings Details
11/13/2012Q3 2012C($0.50)C($0.35)ViewN/AView Earnings Details
8/7/2012Q2 2012C($0.35)C($0.43)ViewN/AView Earnings Details
5/11/2012Q1 2012C($0.30)C($0.51)ViewN/AView Earnings Details
3/27/2012Q4 2011C($0.55)C($0.50)ViewN/AView Earnings Details
11/4/2011Q3 2011C($0.60)C($0.61)ViewN/AView Earnings Details
8/8/2011Q2 2011C($0.55)C($0.64)ViewN/AView Earnings Details
5/16/2011Q1 2011C($0.55)C($0.58)ViewN/AView Earnings Details
3/10/2011Q4 2010C($0.60)C($0.58)ViewN/AView Earnings Details
11/11/2010Q3 2010C$1.00C$1.85ViewN/AView Earnings Details
8/11/2010Q2 2010C$0.35C$0.42ViewN/AView Earnings Details
5/11/2010Q1 2010C$0.50C$1.34ViewN/AView Earnings Details
3/9/2010Q4 2009C($0.40)C$1.00ViewN/AView Earnings Details
11/9/2009Q3 2009C$0.30C($0.05)ViewN/AView Earnings Details
8/11/2009Q2 2009C($0.70)C($0.10)ViewN/AView Earnings Details
5/15/2009Q1 2009C($1.15)C($0.95)ViewN/AView Earnings Details
3/30/2009Q4 2008C($1.10)C($0.70)ViewN/AView Earnings Details
8/12/2008Q2 2008C($1.75)C($1.40)ViewN/AView Earnings Details
5/13/2008Q1 2008C($1.05)C($1.75)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Cardiome Pharma (TSE:COM) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Cardiome Pharma (TSE:COM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Cardiome Pharma (TSE COM) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Cardiome Pharma (TSE:COM)

Cardiome Pharma (TSE COM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/10/2017Jennifer ArchibaldInsiderSell17,164C$2.51C$43,081.64
9/27/2017Jennifer ArchibaldInsiderSell300C$2.56C$768.00
8/25/2017Arthur Henry WillmsDirectorBuy10,000C$2.76C$27,600.00
8/24/2017Justin RenzInsiderBuy10,000C$2.26C$22,600.00
8/23/2017David Cameron Peter DeanInsiderBuy8,500C$2.70C$22,950.00
5/17/2017Justin RenzInsiderBuy10,000C$3.52C$35,200.00
3/27/2015Sheila GrantInsiderSell1,400C$10.64C$14,896.00
3/16/2015Sheila GrantInsiderSell4,700C$11.87C$55,789.00
(Data available from 1/1/2013 forward)

Headlines

Cardiome Pharma (TSE COM) News Headlines

Source:
DateHeadline
Cardiome to Participate in the Cantor Fitzgerald Antibiotics SummitCardiome to Participate in the Cantor Fitzgerald Antibiotics Summit
finance.yahoo.com - January 10 at 9:11 AM
Toronto Exchanges Stock Review, Concordia International, ProMetic Life Sciences, Theratechnologies, and Cardiome PharmaToronto Exchanges Stock Review, Concordia International, ProMetic Life Sciences, Theratechnologies, and Cardiome Pharma
finance.yahoo.com - January 8 at 8:24 AM
BRIEF-Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In RussiaBRIEF-Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
www.reuters.com - December 13 at 9:20 AM
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In RussiaCardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
finance.yahoo.com - December 12 at 9:32 AM
Cardiome Highlights Partner SteadyMeds Agreement With FDA On Pathway To Trevyent NDA ResubmissionCardiome Highlights Partner SteadyMed's Agreement With FDA On Pathway To Trevyent NDA Resubmission
finance.yahoo.com - December 11 at 9:47 AM
Cardiome Announces Xydalba™ Treatment And Patient Experience Presentations At The 2017 National Opat ConferenceCardiome Announces Xydalba™ Treatment And Patient Experience Presentations At The 2017 National Opat Conference
finance.yahoo.com - December 11 at 9:47 AM
Aethlon Medical (AEMD) Appoints Dr. Charles J. Fisher as Board Chairman - StreetInsider.comAethlon Medical (AEMD) Appoints Dr. Charles J. Fisher as Board Chairman - StreetInsider.com
www.streetinsider.com - November 29 at 9:05 AM
Toronto Exchanges Stock Review Healthcare stocks Concordia International, ProMetic Life Sciences, Theratechnologies, and Cardiome PharmaToronto Exchanges Stock Review Healthcare stocks Concordia International, ProMetic Life Sciences, Theratechnologies, and Cardiome Pharma
finance.yahoo.com - November 28 at 8:32 AM
Cardiome to Present at the 29th Annual Piper Jaffray Healthcare ConferenceCardiome to Present at the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 20 at 6:27 PM
Cardiome Pharma Corp. :COM-CA: Earnings Analysis: Q3, 2017 By the Numbers : November 20, 2017Cardiome Pharma Corp. :COM-CA: Earnings Analysis: Q3, 2017 By the Numbers : November 20, 2017
finance.yahoo.com - November 20 at 6:27 PM
Edited Transcript of COM.TO earnings conference call or presentation 14-Nov-17 9:30pm GMTEdited Transcript of COM.TO earnings conference call or presentation 14-Nov-17 9:30pm GMT
finance.yahoo.com - November 16 at 1:02 PM
Cardiome reports 3Q lossCardiome reports 3Q loss
finance.yahoo.com - November 16 at 1:02 PM
BRIEF-Cardiome Q3 loss per share $0.20 - ReutersBRIEF-Cardiome Q3 loss per share $0.20 - Reuters
www.reuters.com - November 15 at 1:42 AM
BRIEF-Cardiome Q3 loss per share $0.20BRIEF-Cardiome Q3 loss per share $0.20
www.reuters.com - November 14 at 8:36 PM
Qu Biologics recruits Ms. Jennifer Archibald, Chief Financial Officer, and Mr. Alun Rees, VP, Manufacturing, to ... - GlobeNewswire (press release)Qu Biologics recruits Ms. Jennifer Archibald, Chief Financial Officer, and Mr. Alun Rees, VP, Manufacturing, to ... - GlobeNewswire (press release)
globenewswire.com - November 9 at 2:49 AM
Cardiome To Hold Third Quarter 2017 Financial Results Conference Call On November 14 - PR Newswire (press release)Cardiome To Hold Third Quarter 2017 Financial Results Conference Call On November 14 - PR Newswire (press release)
www.prnewswire.com - November 9 at 2:49 AM
Cardiome Pharma Corp (COM) Scheduled to Post Earnings on TuesdayCardiome Pharma Corp (COM) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - November 8 at 10:15 AM
What’s Installed For Cardiome Pharma Corp (TSX:COM)?What’s Installed For Cardiome Pharma Corp (TSX:COM)?
finance.yahoo.com - November 7 at 10:36 PM
Cardiome To Hold Third Quarter 2017 Financial Results Conference Call On November 14Cardiome To Hold Third Quarter 2017 Financial Results Conference Call On November 14
finance.yahoo.com - November 7 at 10:36 PM
Cardiome Announces Expansion of Global Geographic Footprint for Brinavess®Cardiome Announces Expansion of Global Geographic Footprint for Brinavess®
finance.yahoo.com - November 2 at 6:18 PM
BRIEF-Cardiome Pharma commercially launches Xydalba in Sweden, Finland and Republic Of IrelandBRIEF-Cardiome Pharma commercially launches Xydalba in Sweden, Finland and Republic Of Ireland
www.reuters.com - October 30 at 4:13 PM
NetworkNewsBreaks - Cardiome Pharma Corp. CRME Initiates Commercial Launch of Xydalba(TM) in Three European CountriesNetworkNewsBreaks - Cardiome Pharma Corp. CRME Initiates Commercial Launch of Xydalba(TM) in Three European Countries
www.marketwatch.com - October 30 at 4:13 PM
Cardiome Announces Commercial Launch of Xydalba™ in Three New European GeographiesCardiome Announces Commercial Launch of Xydalba™ in Three New European Geographies
finance.yahoo.com - October 30 at 4:12 PM
Cardiome Pharma Corp (TSX:COM): Time For A Financial Health CheckCardiome Pharma Corp (TSX:COM): Time For A Financial Health Check
finance.yahoo.com - October 22 at 9:47 PM
Cardiome Pharma Corp (COM) Insider Jennifer Archibald Sells 17,164 SharesCardiome Pharma Corp (COM) Insider Jennifer Archibald Sells 17,164 Shares
www.americanbankingnews.com - October 16 at 4:32 PM
Basilea announces distribution agreement with Cardiome to commercialize antibiotic Zevtera®/Mabelio® (ceftobiprole ... - GlobeNewswire (press release)Basilea announces distribution agreement with Cardiome to commercialize antibiotic Zevtera®/Mabelio® (ceftobiprole ... - GlobeNewswire (press release)
globenewswire.com - September 13 at 11:44 PM
BRIEF-Cardiome announces agreement with BasileaBRIEF-Cardiome announces agreement with Basilea
www.reuters.com - September 12 at 11:05 PM
Cardiome (CRME) Enters Agreement with Basilea for Distribution of Zevtera/Mabelio in Europe and Israel - StreetInsider.comCardiome (CRME) Enters Agreement with Basilea for Distribution of Zevtera/Mabelio in Europe and Israel - StreetInsider.com
www.streetinsider.com - September 12 at 6:05 PM
Cardiome Announces Agreement with Basilea for Distribution of Zevtera®/Mabelio® (Ceftobiprole) in Europe and IsraelCardiome Announces Agreement with Basilea for Distribution of Zevtera®/Mabelio® (Ceftobiprole) in Europe and Israel
finance.yahoo.com - September 12 at 6:05 PM
Basilea announces distribution agreement with Cardiome to commercialize antibiotic Zevtera®/Mabelio® (ceftobiprole) in Europe and IsraelBasilea announces distribution agreement with Cardiome to commercialize antibiotic Zevtera®/Mabelio® (ceftobiprole) in Europe and Israel
feeds.benzinga.com - September 12 at 1:34 AM
Cardiome to Present at the Rodman & Renshaw 19th Annual Global Investment ConferenceCardiome to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
finance.yahoo.com - September 5 at 6:57 PM
Cardiome Pharma (CRME) Says New Data Presented at ESC Highlights Clinical Benefit of BRINAVESS - StreetInsider.comCardiome Pharma (CRME) Says New Data Presented at ESC Highlights Clinical Benefit of BRINAVESS - StreetInsider.com
www.streetinsider.com - August 30 at 6:30 PM
New Data Presented at European Society of Cardiology Congress 2017 Highlights Clinical Benefit of BRINAVESS®New Data Presented at European Society of Cardiology Congress 2017 Highlights Clinical Benefit of BRINAVESS®
finance.yahoo.com - August 30 at 6:30 PM
Insider Buying: Cardiome Pharma Corp (COM) Insider Buys 10,000 Shares of StockInsider Buying: Cardiome Pharma Corp (COM) Insider Buys 10,000 Shares of Stock
www.americanbankingnews.com - August 28 at 4:22 PM
What Falling Estimates & Price Mean for Cardiome (CRME) - Yahoo FinanceWhat Falling Estimates & Price Mean for Cardiome (CRME) - Yahoo Finance
finance.yahoo.com - August 25 at 3:23 PM
What Falling Estimates & Price Mean for Cardiome (CRME)What Falling Estimates & Price Mean for Cardiome (CRME)
finance.yahoo.com - August 25 at 3:23 PM
Cardiome Pharma Corp (COM) Director Acquires C$27,600.00 in StockCardiome Pharma Corp (COM) Director Acquires C$27,600.00 in Stock
www.americanbankingnews.com - August 25 at 1:28 PM
3 Things In Biotech You Should Learn Today: August 24, 20173 Things In Biotech You Should Learn Today: August 24, 2017
seekingalpha.com - August 24 at 5:32 PM
Cardiome Pharma Corp (COM) Insider Purchases C$22,950.00 in StockCardiome Pharma Corp (COM) Insider Purchases C$22,950.00 in Stock
www.americanbankingnews.com - August 24 at 4:20 AM
Cardiome Pharma Corp. (CRME) Sank To An 8-Month Low On FDA NewsCardiome Pharma Corp. (CRME) Sank To An 8-Month Low On FDA News
www.rttnews.com - August 22 at 5:58 PM
FDA: Cardiomes BRINAVESS Data Would Not Be Sufficient To Support ResubmissionFDA: Cardiome's BRINAVESS Data Would Not Be Sufficient To Support Resubmission
www.rttnews.com - August 22 at 3:15 AM
Cardiome Provides U.S. Regulatory Update For BRINAVESSCardiome Provides U.S. Regulatory Update For BRINAVESS
finance.yahoo.com - August 21 at 5:10 PM
Cardiome Pharma Corp. :COM-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 15, 2017Cardiome Pharma Corp. :COM-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 15, 2017
finance.yahoo.com - August 15 at 6:06 PM
Todays Research Reports on Cardiome Pharma Corp., Microbix Biosystems Inc., GeneNews Limited and Essa Pharma Inc.Today's Research Reports on Cardiome Pharma Corp., Microbix Biosystems Inc., GeneNews Limited and Essa Pharma Inc.
finance.yahoo.com - August 11 at 5:51 PM
Brokers Issue Forecasts for Cardiome Pharma Corps FY2017 Earnings (TSE:COM)Brokers Issue Forecasts for Cardiome Pharma Corp's FY2017 Earnings (TSE:COM)
www.americanbankingnews.com - August 11 at 10:45 AM
SteadyMed to Present at the 2017 Wedbush PacGrow Healthcare Conference - NasdaqSteadyMed to Present at the 2017 Wedbush PacGrow Healthcare Conference - Nasdaq
www.nasdaq.com - August 9 at 5:37 PM
Cardiome Reports Second Quarter 2017 Financial Results - PR Newswire (press release)Cardiome Reports Second Quarter 2017 Financial Results - PR Newswire (press release)
www.prnewswire.com - August 9 at 5:37 PM
Edited Transcript of COM.TO earnings conference call or presentation 8-Aug-17 8:30pm GMTEdited Transcript of COM.TO earnings conference call or presentation 8-Aug-17 8:30pm GMT
finance.yahoo.com - August 9 at 5:36 PM
BRIEF-Cardiome Pharma reports quarterly loss per share $0.26BRIEF-Cardiome Pharma reports quarterly loss per share $0.26
www.reuters.com - August 8 at 5:05 PM
Cardiome Reports Second Quarter 2017 Financial ResultsCardiome Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 8 at 5:05 PM

SEC Filings

Cardiome Pharma (TSE:COM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Cardiome Pharma (TSE COM) Stock Chart for Saturday, January, 20, 2018

Loading chart…

This page was last updated on 1/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.